AdvisorNet Financial »

Aclaris Therapeutics shares owned by AdvisorNet Financial

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by AdvisorNet Financial from 13F filings

Historical chart of AdvisorNet Financial investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by AdvisorNet Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by AdvisorNet Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $105 100 1.05
2023-09-30 $685 100 6.85

More positions owned by AdvisorNet Financial

Goldman Sachs Activebeta U.s. Large Cap Equity Etf Etf (GSLC)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Microsoft Stock (MSFT)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares S&p 500 Index Etf (IVV)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Schwab Us Dividend Equity Etf Etf (SCHD)
Dimensional U.s. Small Cap Etf Etf (DFAS)
Dimensional Us Core Equity Market Etf Etf (DFAU)
Ishares Aggregate Bond Etf Etf (AGG)
Spdr S&p 500 Etf Etf (SPY)
Vanguard Growth Etf Etf (VUG)
Ishares Dj Us Technology Etf (IYW)
Schwab Short Term Us Treasury Etf Etf (SCHO)

View all positions for AdvisorNet Financial

Top funds holding Aclaris Therapeutics

BML Capital Management
Citadel Advisors
Vanguard Group
Millennium Management
D. E. Shaw & Co
Tang Capital Management
GSA Capital Partners
Two Sigma Investments
Two Sigma Advisers
Monaco Asset Management SAM
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Samsara BioCapital
Goldman Sachs Group
Citigroup

View all funds holding Aclaris Therapeutics